Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Corlux prevents olanzapine-induced weight gain in rats

April 25, 2005

European approval for Aclasta in Paget's disease of the bone

April 22, 2005

GlaxoSmithKline claims new compounds for the treatment of anemia

April 21, 2005

Update on the weight effects of AOD-9604 in obese patients

April 21, 2005

Novel MCH-R1 antagonist synthesized and tested

April 21, 2005

FDA 510(k) clearance for Cumulase

April 21, 2005

Neurocrine reports new agents for gynecological disorders

April 20, 2005

Effects of ospemifene and raloxifene compared in postmenopausal women

April 20, 2005

New European approval for InductOs

April 20, 2005

Withdrawal of European marketing authorizations for Venvia/Nyracta

April 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...